您的位置: 首页 > 农业专利 > 详情页

THYMOSINE BETA 4 POUR L'UTILISATION DANS LE TRAITEMENT D'UNE BLESSURE DE NEURONES
专利权人:
Henry Ford Health System
发明人:
申请号:
EP10756916.2
公开号:
EP2411036B1
申请日:
2010.03.26
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Thymosin &bgr;4 can be used to treat neuronal and brain injuries that are accompanied by neuronal cell death or injury, including injuries caused by stroke or trauma and injuries caused by neurological and neurodegenerative disease. In particular, stroke and multiple sclerosis are examples of conditions which may be ameliorated by treatment with thymosin &bgr;4. Thymosin &bgr;4 has been found to restore neurological tissue through several effects on several neurological parameters which are improved by administration of thymosin &bgr;4 to a subject in need of neurological tissue restoration. For example, thymosin &bgr;4 improves axonal myelination, migration of neural progenitor cells, neural progenitor cell proliferation, differentiation of neural progenitor cells into mature neurons, differentiation of neural progenitor cells into mature glia, nerve regeneration, and brain remodeling at locations of brain injury.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充